Action for ME
Action for ME, or AfME, is a patient charity registered in England and Wales: 1036419 and registered in Scotland: SC040452.
- 1 Aims
- 2 History
- 3 Notable people
- 4 Funding
- 5 Controversy and conflicts of interest
- 6 Involvement in PACE trial controversy
- 7 Membership
- 8 Trustees
- 9 Online presence
- 10 Charities commission and financial details
- 11 See also
- 12 Learn more
- 13 References
Aims[edit | edit source]
The 2013 Action for ME Statement of Strategic Intent outlines three strategic touchstones for 2013-2016: Inform and Influence, Empower and Support, Research. Their priorities are: Awareness and understanding, health, welfare, research, employment.
Our vision, mission and values
- Our vision is a world without M.E.
- Our mission is empowering people with M.E. to fulfill their potential and secure the care and support they need, while working towards a greater understanding of the illness and ultimately a cure.
- Shared values are held with high regard in our organisation and reflect how we seek to work with our supporters, partners and other key stakeholders. They reflect the attitudes, beliefs and behaviour that we value in each other and underpin our whole approach and culture.
History[edit | edit source]
The charity was set up in 1987 as The M.E. Action Campaign. Its founders were Martin Lev, Sue Findlay and Clare Francis. In September 1993 it changed its name and logo to Action for ME and Chronic Fatigue. It then changed its name in 1993 to Action for ME.
In April 2017 it merged with Association of Young People with ME.
AfME has for years provided the joint secretariat for the All Party Parliamentary Group on ME in the UK Westminster Parliament.
Notable people[edit | edit source]
- Sonya Chowdhury (Chief Executive)
- Julia Newton (Joint Medical Advisor)
- Gregor Purdie (Joint Medical Advisor)
Funding[edit | edit source]
Action for M.E. has received UK government Department of Health (DoH) funding. It also receives funding from the Scottish Government. AFME now claims it receives no government funding. It states it support also comes from public and corporate donations.
AfME has not been transparent about its funding. It has resulted in questions even being asked in Parliament about some of its funding from the UK government. The Countess of Mar asked:
“How much funding has been awarded by the Department of Health under Section 64 of the Health Services and Public Health Act 1968 to the United Kingdom charity Action for ME since April 2003; for what purpose the award was made; and what were the terms under which it was made; and Whether any funding has been awarded by the Department of Health under Section 64 of the Health Services and Public Health Act 1968 to any charities representing those with myalgic encephalomyelitis or chronic fatigue syndrome other than Action for ME since April 2003; if so, how much was awarded; to which charities; and for which purpose.”
Lord Warner (Health) responded “In February 2003, Action for Myalgic Encephalomyelitis (ME) was awarded a grant of £187,000 over a three-year period to support its chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) clinical network project. The project is intended to help all those in the field to access knowledge and share best practice on meeting the needs of patients. The Association for Youth with ME was awarded a grant in 2002 of £110,000 over a three-year period in respect of its positive living project. This involves developing a training and information programme to empower children and young people via skills workshops to voice their experience, knowledge and needs of living with CFS/ME. All voluntary organisations awarded Section 64 grants provide regular progress reports showing how they meet the objectives laid down by the grant conditions.”
Controversy and conflicts of interest[edit | edit source]
Change of charity name[edit | edit source]
In September 1993 it changed its name and logo to "Action for ME and Chronic Fatigue". Complaints were made to the Charity Commission, as “chronic fatigue” is a symptom distinct from ME and CFS, and the charity subsequently dropped Chronic Fatigue.
Criticism from some ME advocates and charities[edit | edit source]
Some ME advocates have stated that there are many reasons to not support AfME, including an article detailing numerous reasons not to support AfME. Some other ME charities have refused to work with AfME.
In a 2004 House of Lords debate, Action for ME's involvement with Professor Simon Wessely was criticised as it was supporting the Wessely school's CBT/GET management programme and was actively involved in the development of the new CBT/GET treatment centres.
In 2013 AfME relaunched its research strategy with ‘Action for M.E. – Placing Patient Views at the Heart of a New Research Strategy’. Its Chief Executive answered questions about the new strategy and also about the commitment to greater patient involvement on the forum Phoenix Rising. There were questions unanswered about the PACE trial, including some by Robert Courtney.
Research funding controversies[edit | edit source]
AfME had close links with the insurance industry and psychiatrists who work with the insurance industry and the Department for Work and Pensions. AfME's former chairman, Alan Cook, was previously a chairman of an insurance company.
Patient advocacy[edit | edit source]
AfME also supported the controversial CFS/ME NICE guidelines in 2007 which were opposed by all other patient groups and charities and did not support the judicial review against them. Action for ME Chief Executive at the time, Chris Clark, had been involved in drawing up the 2007 NICE guidelines, and had accepted considerable input from Simon Wessely about the research findings for ME/CFS treatments.
Action for ME did not sign the open letter to Psychological Medicine signed by over 100 signatories including scientists and charities. Numerous patients requested and appealled to AfME to sign an open letter to Psychological Medicine in March of 20?? but after a two-month delay they issued their statement in May. AfME published its response to patient concerns regarding the use of cognitive behavioral therapy (CBT) and graded exercise therapy (GET) and the PACE trial for patients and their failure to sign to the open letter to Psychological Medicine.
Despite repeated requests, AfME did not make a statement about a talk that Esther Crawley, who is closely associated with the charity and receives funding from AfME, presented at a renal conference that allegedly maligned patients and allegedly accused David Tuller of libel.
#millionsmissing campaign[edit | edit source]
Funding research by Esther Crawley[edit | edit source]
AfME obtained money from a private corporate donor and announced that this anonymous corporate donation would fund the work of the researcher Esther Crawley and her Severe Pediatric Study via the charity. This was questioned and criticized by ME sufferers in forums but AfME removed many posts as they claimed they were defamatory for asking such questions and stated the donation was from "private corporate donor with a specific interest in seeing the alleviation of childhood suffering." In 2018 it was announced that AfME would not be funding that research, but did not provide a full explanation of the sources of the money and the reasons for doing so. AfME stated the donation would be used directly to support children instead, and that this had been agreed with the donor.
AfME have created and organised the "M.E./CFS International Alliance", a group involving M.E. advocates and charity representatives from six countries. However some organisations stated they weren't aware of their membership and ME patients have expressed concerns due to its history. AfME have been protesting at the World Health Organization (WHO) in Geneva, Switzerland, under the Millions Missing campaign however patients have expressed concerns due to the WHO accepting ME as a neurological disease since 1969.
Criticism from other patient advocacy groups[edit | edit source]
Involvement in PACE trial controversy[edit | edit source]
AfME were involved from the beginning by supporting the PACE trial and its researchers from 2003. Archives are available of their involvement as their website pages of this involvement have been deleted. The PACE trial would not have been funded or conducted without patient support, which AFME provided.
- "Despite the anger in the patient community, the investigators were able to enlist Action for ME, another major advocacy group, to help design the pacing intervention. They called their operationalization of the strategy “adaptive pacing therapy,” or APT."
- The Oxford criteria was used for PACE trial participation. The PACE trial was designed with input from the charity, Action for ME.
- "From the outset, Action for M.E. and a number of patients were involved in the design of the trial."
- "The major innovations in this application include close collaboration with Action for ME."
Action for ME provided the requisite 'patient support' regularly cited by the PACE trial authors and collaborators since its inception in 2005 and had refused to support many patients exposing the flaws in the trial for years or criticise the flaws in the trial. It had ignored these flaws for years despite ME sufferers pointing these out and working for years to expose the trial. AfME's public positions on the trial began shifting after patients and other scientists had finally discredited the trial.
Dr David Tuller publicly suggested in a forum on June 18th of 20?? that he would also write about AfME when he has time and is able to and stated AfME have made no apology for enabling and abetting PACE and that AfME really should take responsibility for that at this stage. AfME then asked to sign Dr Tuller's letter on June 20th of 20??. This apparent change of position was the day before Carol Monaghan MP's second parliamentary debate.
On August 21, 2018, The Times ran an article about an open letter to the Lancet which more than a hundred academics, ten MPs, and patient groups from around the world had signed. On August 29, 2018, Action for ME posted a statement on their new position on the PACE trial and behavioral treatments for M.E.
PACE trial apology[edit | edit source]
Membership[edit | edit source]
Unlike most charities and many ME charities, AFME does not allow its paying members to become legal members of the charity and therefore have no input into the direction of the charity and voting rights.It only recognizes its own trustees as members. Action for ME states that Supporting and Lifelong members can vote on "a selection of new and returning trustees."
Trustees[edit | edit source]
- Jonah Grunsell, who has been Chair of Board of Trustees since November 2016. Jonah replaced Alan Cook.
- Philip Marsden, Action for ME Treasurer, is a chartered accountant, a director of a corporate finance advisory company and a non-executive director of two investment trusts. Philip's son was diagnosed with ME in 2003.
- Chris Cundy who is serving his third term as trustee. Chris is a chartered accountant and company director.
- Jane Young, a consultant radiologist. Jane and her son have both recovered from ME
- Jane Logan, who has been diagnosed with ME, is a senior lecturer in midwifery.
- Dr Gregor Purdie, former Clinical Lead for ME for NHS Dumfries and Galloway, now retired, co-authored the Scottish Good Practice Statement on ME/CFS. Dr Purdie is one of Action for ME's Medical Advisers.
- Jane Stacey, who had a career in social work before becoming Deputy Chief Executive at Barnardo's.
- Sue Hardy, who has had ME for more than 16 years. She worked as a nurse and senior lecturer until she suffered a relapse and took medical retirement.
- Gordon Berry, who was diagnosed with ME after 25 years of illness. He now runs a business troubleshooting consultancy, and has held charitable roles as a Trustee and Chair.
- Matt Symonds who first became aware of Action for ME when attending the Speaker's House reception at the UK parliament in 2016.
- Colin Batten was appointed a trustees in 2017, following the merger with the Association of Young People with ME, where he was on the Board.
- Andy Dougan, a senior marketing and advertising executive, who witnessed a close friend struggle with ME in childhood.
- Ed Stephens, Head of Global Brokerage and Partnerships at Angel Investment Network, which matches investors to entrepreneurs.
- Phil Murray was diagnosed with ME in 1997, and has been mainly in remission since 2007. Phil has worked extensively with Westcare_UK, sat on the ME patient advisory group for MEGA, attended the NICE guidelines scoping meeting in 2918, and co-organised a Millions Missing protest.
- Alison Deeth, who was diagnosed with ME in 2005. She is a former solicitor.
Online presence[edit | edit source]
Charities commission and financial details[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ME, Action for. "Home". Action for ME. Retrieved Aug 19, 2019.
- ME, Action for. "Our strategic touchstones". Action for ME. Retrieved Aug 19, 2019.
- Action for ME Statement of Strategic Intent - 2013-2016
- Our vision, mission and values - Action for ME
- "Action for ME". Wikipedia. Nov 5, 2016.
- Action for ME - About Us - CEO
- Action for ME - Make a Difference
- "Lords Hansard text for 11 Feb 2004 (240211w03)". publications.parliament.uk. Retrieved Aug 31, 2019.
- "16 Good Reasons to be very suspicious of Action for ME". 16 Good Reasons to be very suspicious of Action for ME. Retrieved Aug 19, 2019.
- "Myalgic Encephalomyelitis - Hansard". hansard.parliament.uk. Retrieved Aug 31, 2019.
- "Action for M.E. - Placing Patient Views at the Heart of a New Research Strategy". Phoenix Rising ME / CFS Forums. Retrieved Aug 31, 2019.
- ME, Action for. "Questions and answers". Action for ME. Retrieved Aug 31, 2019.
- ME, Action for. "Paediatric M. E. research study: alternative funding". Action for ME. Retrieved Aug 31, 2019.
- ME, Action for. "What is the neurophysiology of pain in ME study about?". Action for ME. Retrieved Aug 31, 2019.
- "UnumProvident - CMOReport2002". web.archive.org. Oct 9, 2006. Retrieved Aug 19, 2019.
- "ME Association fully supports legal challenge to the NICE Guideline on ME/CFS". meagenda.wordpress.com. Feb 6, 2009.
- meagenda (Aug 1, 2009). "Concerning a recent statement and report published in the wake of the Judicial Review of the NICE Guidelines on CFS/ME". ME agenda. Retrieved Aug 31, 2019.
- Tuller, David. "An open letter to Psychological Medicine, again!". www.virology.ws. Retrieved Aug 31, 2019.
- ME, Action for. "Our Board of Trustees on CBT, GET and PACE". Action for ME. Retrieved Aug 31, 2019.
- Chowdhury, Sonya (May 12, 2017). "Thanks so much @EmilyBeardall1 for promoting me. Can't believe 100 days has passed and we have done it! #millionsmissing". @SonyaChowdhury. Retrieved Aug 31, 2019.
- ME, Action for. "Questions and answers". Action for ME. Retrieved Aug 19, 2019.
- "Esther Crawley Paediatric Prevalence Study Funded by Action for ME". Phoenix Rising ME / CFS Forums. Retrieved Aug 19, 2019.
- "Action for ME terminates, by mutual agreement with the University of Bristol, contract to fund Crawley study". Science for ME. Retrieved Aug 31, 2019.
- "New Org!: ME/CFS International Alliance". Phoenix Rising ME / CFS Forums. Retrieved Aug 31, 2019.
- World Health Organization (1969). International Classification of Diseases (PDF). 2 (Eighth revision ed.). Geneva: WHO. p. 173.
(myalgic, benign) 323
- Bryant, Jane (Aug 2006). "THE AFME DOSSIER: A DOSSIER OF CONCERNS ABOUT THE CHARITY ACTION for ME (AfME)". THE ONE CLICK GROUP.
- "Action for M.E. News - PACE Research Study Q&A". web.archive.org. Aug 4, 2003. Retrieved Aug 31, 2019.
- Tuller, David. "TRIAL BY ERROR: The Troubling Case of the PACE Chronic Fatigue Syndrome Study". www.virology.ws. Retrieved Aug 31, 2019.
- Pace Trial - Centre for Psychiatry - QMUL
- "PACE study results – Medical Research Council (UK) news report, 18 February 2011". Retrieved Aug 31, 2019.
- "Analysis of PACE Trial Results". www.ayme.org.uk. Retrieved Aug 31, 2019.
- Comment on the statement by Sir Peter Spencer of Action for ME Margaret Williams - 19th April 2011
- "Action for ME have "reworked our treatment and symptom management page" and "updated our pages on GET and CBT"". Science for ME. Retrieved Aug 19, 2019.
- Science Editor, Tom Whipple (Aug 21, 2018). "Call for review of 'flawed' ME research in Lancet letter". The Times. ISSN 0140-0460. Retrieved Aug 29, 2018.
- Chowdhury, Sonya; Action for ME (Aug 2018). "The PACE trial and behavioural treatments for M.E." Action for ME. Archived from the original on Aug 29, 2018. Retrieved Aug 29, 2018.
- Action for ME. "What was the PACE trial?". Action for ME. Retrieved Aug 30, 2019.
- Action for ME (Jun 28, 2018). "Correcting some inaccuracies about us and our work". Action for ME. Retrieved Feb 16, 2019.
- Action for ME. "Board of Trustees". Retrieved Feb 16, 2019.